−0.10SEK
−1.81 MSEK
25.03 MSEK
About CORLINE BIOMEDICAL AB
Sector
Industry
CEO
Lars Henrik Nittmar
Website
Headquarters
Uppsala
Founded
1991
ISIN
SE0006887451
FIGI
BBG009BHZN38
Corline Biomedical AB engages in the research, development, and commercialization of heparin based solutions. Its products intend to improve kidney transplantation, cell therapies, and applications. The firm operates under the following trademarks: CHC, Renaparin, Cytoparin, and CHS. The company was founded in 1991 and is headquartered in Uppsala, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CLBIO is 10.90 SEK — it has decreased by 0.91% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange CORLINE BIOMEDICAL AB stocks are traded under the ticker CLBIO.
CLBIO stock is 1.85% volatile and has beta coefficient of −0.46. Check out the list of the most volatile stocks — is CORLINE BIOMEDICAL AB there?
Yes, you can track CORLINE BIOMEDICAL AB financials in yearly and quarterly reports right on TradingView.
CLBIO stock has fallen by 7.23% compared to the previous week, the month change is a 8.40% fall, over the last year CORLINE BIOMEDICAL AB has showed a 14.50% increase.
CLBIO net income for the last quarter is −600.00 K SEK, while the quarter before that showed 179.00 K SEK of net income which accounts for −435.20% change. Track more CORLINE BIOMEDICAL AB financial stats to get the full picture.
Today CORLINE BIOMEDICAL AB has the market capitalization of 236.40 M, it has increased by 0.42% over the last week.
No, CLBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CLBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CORLINE BIOMEDICAL AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CORLINE BIOMEDICAL AB technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CORLINE BIOMEDICAL AB stock shows the sell signal. See more of CORLINE BIOMEDICAL AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CORLINE BIOMEDICAL AB EBITDA is −363.00 K SEK, and current EBITDA margin is −1.45%. See more stats in CORLINE BIOMEDICAL AB financial statements.